TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED

Share ownership Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

600329

CNE000001808

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-04-21			5-day change	1st Jan Change
40.68 ^CNY	+0.30%		+0.05%	-10.83%

Mar. 31	Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025	MT
Mar. 31	Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20%	MT

Share class: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	200,000,000	0	0	31.72 %
Stock B	1	570,094,356	244,268,748 ( 42.85 %)	0

Major shareholders: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Name	Equities	%	Valuation
Jinhushen Biomedical Technology Co., Ltd. 58.4 %	331,202,728	58.4 %	1 961 M ¥
FUTU HOLDINGS LIMITED 1.76 %	9,982,715	1.76 %	59 M ¥
China Southern Asset Management Co., Ltd. 0.7534 %	4,272,650	0.7534 %	25 M ¥
Fullgoal Fund Management Co., Ltd. 0.3032 %	1,719,558	0.3032 %	10 M ¥
Penghua Fund Management Co., Ltd. 0.1823 %	1,033,899	0.1823 %	6 M ¥
China Asset Management Co., Ltd. 0.1485 %	842,302	0.1485 %	5 M ¥
CCB Principal Asset Management Co., Ltd. 0.1046 %	593,100	0.1046 %	4 M ¥
Tian Hong Asset Management Co., Ltd. 0.091 %	515,800	0.091 %	3 M ¥
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt) 0.0269 %	152,455	0.0269 %	902 610 ¥
Huatai-PineBridge Fund Management Co., Ltd. 0.0194 %	109,995	0.0194 %	651 225 ¥
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Phillip Capital Management (S) Ltd. 0.0787 %	157,400	0.0787 %	508 402 ¥

Breakdown by shareholder type

Other	58.41%
Institutional	1.83%
Futu Holdings Ltd.	1.76%
Unknown	38%

Based on 1000 largest holdings

Geographical origin of shareholders

China	60.19%
Hong Kong	1.78%
Singapore	0.03%

Based on 1000 largest holdings

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd, formerly Tianjin Zhongxin Pharmaceutical Group Co Ltd, is a China-based company mainly engaged in the production, operation and scientific research of green traditional Chinese medicine. The Company's businesses cover the whole industry chain of traditional Chinese medicine, including the cultivation of Chinese medicinal materials, trade of Chinese medicinal materials, research and development (R&D), production and sales of Chinese patent medicines, production and sales of Chinese herbal decoction pieces, pharmaceutical commercial logistics, pharmaceutical retailing, chemical raw materials and preparations, biomedicine and many other fields. The Company's products include cardiovascular and cerebrovascular medicines, respiratory medicines, spleen and stomach medicines, cold medicines, oncology medicines, gynecological medicines, pediatric medicines and other other product groups.

Employees

3,890

Sector

Pharmaceuticals

Calendar

Apr. 30 - Earnings release - Q1 2026

More about the company